Phase 3 Study Shows Doravirine/Islatravir Combination Equivalent to Three-Drug Regimen in Naïve Patients
A recent Phase 3 clinical trial has demonstrated that a dual-drug oral regimen, combining doravirine and islatravir, is non-inferior to standard three-drug antiretroviral therapy (ART) in treatment-naive HIV patients. This ... Read More